Hans Bitter
SVP and Head of Computational Sciences @ MOMA Therapeutics
0zlnyf4@61p2wf.p5g
Sign up to see email
Known information
About MOMA Therapeutics
MOMA Therapeutics is a biotechnology company specializing in the discovery of precision medicines by targeting molecular machines involved in human diseases, having raised $150M in Series B funding.